Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study.

@article{Pizzocaro1986AdjuvantMA,
  title={Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study.},
  author={Giorgio Pizzocaro and Luigi Piva and Roberto Salvioni and Giovanni Di Fronzo and E. Ronchi and Patrizia Miodini},
  journal={The Journal of urology},
  year={1986},
  volume={135 1},
  pages={18-21}
}
From July 1, 1979 to June 30, 1983, 136 consecutive patients with category M0 renal cell cancer who had undergone transperitoneal radical nephrectomy at 5 centers entered a prospective randomized trial to compare 500 mg. adjuvant medroxyprogesterone 3 times a week for 1 year to no treatment. Sex steroid hormone receptors also were studied in the renal tumor… CONTINUE READING